Please login to the form below

Not currently logged in
Email:
Password:

hearing loss

This page shows the latest hearing loss news and features for those working in and with pharma, biotech and healthcare.

Novartis buys gene therapy firm AveXis for $8.7bn

Novartis buys gene therapy firm AveXis for $8.7bn

Along with AVXS-101, AveXis’pipeline also includes two candidates for hearing loss and eye disorder retinitis pigmentosa in phase I testing, as well as preclinical programmes in genetic neurological disorder

Latest news

More from news
Approximately 1 fully matching, plus 18 partially matching documents found.

Latest appointments

  • John LaMattina joins Frequency Therapeutics in advisory role John LaMattina joins Frequency Therapeutics in advisory role

    Frequency Therapeutics has appointed John LaMattina as its senior advisor to the CEO in a role that will see him focus on assisting its development of a treatment for hearing loss, ... He said: “It is my pleasure to join Frequency Therapeutics as it

  • Sue Ryder appoints head of PR, celebrity and communications Sue Ryder appoints head of PR, celebrity and communications

    She brings with her 15 years of communications experience, most recently at sight loss charity RNIB, where she led PR activities, developing several national consumer-facing fundraising and brand-building campaigns. ... Previous roles include head of

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • CES 2017 – Medical Device Top Picks

    with hearing loss to personalize day to day listening situations on an app. ... ReSound says that the result is clearer sound and a ‘ vivid sense of space’ that can help users better manage the impact of living with diminished hearing.

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is a creative agency specialising in healthcare communication and understanding people's personality types....

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics